🇯🇵 Immucillin H in Japan

PMDA authorised Immucillin H on 30 March 2017

Marketing authorisation

PMDA — authorised 30 March 2017

  • Marketing authorisation holder: Mundi Pharma
  • Status: approved

Immucillin H in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Japan

Frequently asked questions

Is Immucillin H approved in Japan?

Yes. PMDA authorised it on 30 March 2017.

Who is the marketing authorisation holder for Immucillin H in Japan?

Mundi Pharma holds the Japanese marketing authorisation.